Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoatrophic Diabetes Mellitus”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Ended earlyNCT00521820
What this trial is testing

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure

Who this might be right for
Diabetes Mellitus
Takeda 518
Testing effectiveness (Phase 2)Study completedNCT00760344
What this trial is testing

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 386
Large-scale testing (Phase 3)Study completedNCT00395512
What this trial is testing

Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 655
Large-scale testing (Phase 3)Study completedNCT00770952
What this trial is testing

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 91
Post-approval studies (Phase 4)Study completedNCT00494312
What this trial is testing

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Who this might be right for
Diabetes MellitusLiver
Takeda 2,120
Large-scale testing (Phase 3)Study completedNCT00286442
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 527
Large-scale testing (Phase 3)Study completedNCT00286455
What this trial is testing

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 329
Large-scale testing (Phase 3)Study completedNCT00286494
What this trial is testing

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 493
Not applicableStudy completedNCT00449553
What this trial is testing

Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

Who this might be right for
Diabetes Mellitus
Takeda 326
Testing effectiveness (Phase 2)Study completedNCT00025883
What this trial is testing

Leptin to Treat Lipodystrophy

Who this might be right for
Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 103
Testing effectiveness (Phase 2)Study completedNCT03514420
What this trial is testing

Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)

Who this might be right for
Familial Partial Lipodystrophy
Akcea Therapeutics 4
Large-scale testing (Phase 3)Study completedNCT00225264
What this trial is testing

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

Who this might be right for
Diabetes Mellitus
Takeda 458
Large-scale testing (Phase 3)Ended earlyNCT00762190
What this trial is testing

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 348
Large-scale testing (Phase 3)UnknownNCT04221152
What this trial is testing

A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )

Who this might be right for
Insulin Resistance - Type AInsulin Resistance - Type BLipoatrophic Diabetes Mellitus+1 more
Kobe University 8
Testing effectiveness (Phase 2)Ended earlyNCT00722917
What this trial is testing

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 323
Large-scale testing (Phase 3)Ended earlyNCT00762684
What this trial is testing

Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 8
Large-scale testing (Phase 3)Study completedNCT00225277
What this trial is testing

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 547
Post-approval studies (Phase 4)Study completedNCT00672919
What this trial is testing

Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Who this might be right for
Diabetes Mellitus
Takeda 305
Testing effectiveness (Phase 2)Study completedNCT00762736
What this trial is testing

Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 704
Testing effectiveness (Phase 2)Study completedNCT00676260
What this trial is testing

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Who this might be right for
Diabetes Mellitus
Takeda 29
Load More Results